Media Room
Explore our latest press releases, announcements, and updates on groundbreaking immunotherapy research.
For media inquiries, please contact us at [email protected].
-
Media Room Article
Cancer Research Institute (CRI) Appoints Alicia Zhou, PhD, as Chief Executive Officer to Advance Next Generation of Cancer Immunotherapy Science and Innovation
NEW YORK, NY — The Cancer Research Institute (CRI), the preeminent nonprofit organization focused on advancing breakthroughs… -
Media Room Article
Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD
NATIONAL HARBOR, MD – The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI)… -
Media Room Article
The 2024 Impact Report of the Cancer Research Institute
Executive Summary Since our founding in 1953, the Cancer Research Institute (CRI) has been at the forefront… -
Media Room Article
Cancer Research Institute Awards Over $22 Million in Grants to Fuel Immunotherapy Innovations
NEW YORK – August 8, 2024 — As the leading nonprofit organization committed to revolutionizing cancer treatment… -
Media Room Article
Cancer Research Institute Announces New Lloyd J. Old STARs Class
New York, NY – August 5, 2024 – The Cancer Research Institute (CRI) proudly announces the newest… -
Media Room Article
Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer
REDWOOD CITY, Calif., May 8, 2024 — Coherus BioSciences, Inc. (Coherus; Nasdaq: CHRS) today announced that the… -
Media Room Article
New Survey of U.S. Oncologists Reveals Where More Work Can Be Done to Research Treatments for Advanced Non-Small Cell Lung Cancer
Survey examined oncologists’ perspective on treatment options and priorities, comorbidities and other clinical characteristics of patients with… -
Media Room Article
CRI CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey on Immunotherapy and Her Tenure
NEW YORK – Jill O’Donnell-Tormey, PhD, CEO and director of scientific affairs at the Cancer Research Institute… -
Media Room Article
Cancer Research Institute Joins Lance Kawaguchi, #SouthPoleTrek4Cancer to Ring the Nasdaq Stock Market Closing Bell
Contact: Melinda Koski, SouthPoleTrek4Cancer Sharon Slade, Chief Marketing Officer, CRI For Immediate Release Tuesday, December 19, 2023…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.